Earnings

Danaher returns a key business to growth, and we’re raising our stock rating back to buy

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 
Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter.

Articles You May Like

Beauty stocks post major losses after a week of worrying results
Why benefit increases prompted by the Social Security Fairness Act may be difficult to implement
Sell McDonald’s on Monday’s gains, Main Street Research investor says
Why Do We Avoid The Things That Matter Most? Greg McKeown And An “Essentialist” Approach To Personal Finance
Trump 2.0 may create powerful tailwinds for two vastly different groups: big banks and small caps

Leave a Reply

Your email address will not be published. Required fields are marked *